1,834 Blueprint Medicines Co. shares sold by Insider Ariel Hurley for $190,515.92 on May 2nd.

Insider Ariel Hurley sold 1,834 shares of Blueprint Medicines Co. (NASDAQ:BPMC) stock for $190,515.92 on May 2nd, leaving them with 14,913 shares. The company's stock price opened at $108.78 on the same day. Goldman Sachs recently raised its price target for BPMC to $168.00, while Leerink Partners predicts FY2027 earnings of $5.34 per share. Analysts at Barclays, Citigroup, HC Wainwright, and SVB Leerink have also issued research reports on the company, with some increasing their price targets.

May 09, 2024
5 Articles